Drug Topics March 26, 2025
Killian Meara, Rob Frankil, RPh

A conversation with Rob Frankil, RPh, executive director of the Philadelphia Association of Retail Druggists.

Over 300 pharmacies in the United States have closed since late December 2024, according to an analysis from the American Economic Liberties Project.1 In the report, the authors laid the blame largely on pharmacy benefit managers (PBM) and the abandonment of reforms by Congress.

Emma Freer, senior policy analyst for healthcare at the Economic Liberties Project, said in a release that “without Congressional intervention, the Big Three PBMs [CVS Caremark, Express Scripts, and OptumRx] have continued to abuse their market power, squeezing at least 326 pharmacies—237 of them independent—out of business in fewer than 10 weeks and stranding their most vulnerable patients in pharmacy deserts...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Interview / Q&A, Pharma, Pharma / Biotech, Trends
The Case for 340B Done Right
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Faster Cancer Drug Approvals Tied to Clinical Benefits
Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for Years
The Future of PBMs in 2025: AI, Regulations, and Transparency Initiatives

Share This Article